Author
Listed:
- Samuel J. Rodgers
(Monash University
Monash University)
- Lisa M. Ooms
(Monash University
Monash University)
- Viola M. J. Oorschot
(Monash University
Electron Microscopy Core Facility, European Molecular Biology Laboratory)
- Ralf B. Schittenhelm
(Monash University)
- Elizabeth V. Nguyen
(Monash University
Monash University)
- Sabryn A. Hamila
(Monash University
Monash University)
- Natalie Rynkiewicz
(Monash University
Babraham Institute)
- Rajendra Gurung
(Monash University
Monash University)
- Matthew J. Eramo
(Monash University
Monash University)
- Absorn Sriratana
(Monash University
Monash University)
- Clare G. Fedele
(Monash University
University of Melbourne)
- Franco Caramia
(University of Melbourne)
- Sherene Loi
(University of Melbourne)
- Genevieve Kerr
(Monash University
Monash University)
- Helen E. Abud
(Monash University
Monash University)
- Georg Ramm
(Monash University
Monash University
Monash University)
- Antonella Papa
(Monash University
Monash University)
- Andrew M. Ellisdon
(Monash University
Monash University
Monash University)
- Roger J. Daly
(Monash University
Monash University)
- Catriona A. McLean
(Department of Anatomical Pathology, Alfred Hospital)
- Christina A. Mitchell
(Monash University
Monash University)
Abstract
INPP4B suppresses PI3K/AKT signaling by converting PI(3,4)P2 to PI(3)P and INPP4B inactivation is common in triple-negative breast cancer. Paradoxically, INPP4B is also a reported oncogene in other cancers. How these opposing INPP4B roles relate to PI3K regulation is unclear. We report PIK3CA-mutant ER+ breast cancers exhibit increased INPP4B mRNA and protein expression and INPP4B increased the proliferation and tumor growth of PIK3CA-mutant ER+ breast cancer cells, despite suppression of AKT signaling. We used integrated proteomics, transcriptomics and imaging to demonstrate INPP4B localized to late endosomes via interaction with Rab7, which increased endosomal PI3Kα-dependent PI(3,4)P2 to PI(3)P conversion, late endosome/lysosome number and cargo trafficking, resulting in enhanced GSK3β lysosomal degradation and activation of Wnt/β-catenin signaling. Mechanistically, Wnt inhibition or depletion of the PI(3)P-effector, Hrs, reduced INPP4B-mediated cell proliferation and tumor growth. Therefore, INPP4B facilitates PI3Kα crosstalk with Wnt signaling in ER+ breast cancer via PI(3,4)P2 to PI(3)P conversion on late endosomes, suggesting these tumors may be targeted with combined PI3K and Wnt/β-catenin therapies.
Suggested Citation
Samuel J. Rodgers & Lisa M. Ooms & Viola M. J. Oorschot & Ralf B. Schittenhelm & Elizabeth V. Nguyen & Sabryn A. Hamila & Natalie Rynkiewicz & Rajendra Gurung & Matthew J. Eramo & Absorn Sriratana & C, 2021.
"INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer,"
Nature Communications, Nature, vol. 12(1), pages 1-19, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23241-6
DOI: 10.1038/s41467-021-23241-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23241-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.